MX350201B - Composiciones oftalmicas con ceras alcoxiladas naturales. - Google Patents

Composiciones oftalmicas con ceras alcoxiladas naturales.

Info

Publication number
MX350201B
MX350201B MX2014009949A MX2014009949A MX350201B MX 350201 B MX350201 B MX 350201B MX 2014009949 A MX2014009949 A MX 2014009949A MX 2014009949 A MX2014009949 A MX 2014009949A MX 350201 B MX350201 B MX 350201B
Authority
MX
Mexico
Prior art keywords
ophthalmic compositions
alkoxylated
natural waxes
alkoxylated natural
ophthalmic
Prior art date
Application number
MX2014009949A
Other languages
English (en)
Other versions
MX2014009949A (es
Inventor
Xia Erning
Fridman Krista
Original Assignee
Bausch & Lomb
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bausch & Lomb filed Critical Bausch & Lomb
Publication of MX2014009949A publication Critical patent/MX2014009949A/es
Publication of MX350201B publication Critical patent/MX350201B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/36—Caryophyllaceae (Pink family), e.g. babysbreath or soapwort
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L12/00—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor
    • A61L12/08—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor using chemical substances
    • A61L12/14—Organic compounds not covered by groups A61L12/10 or A61L12/12
    • A61L12/141—Biguanides, e.g. chlorhexidine
    • A61L12/142—Polymeric biguanides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D1/00—Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
    • C11D1/66—Non-ionic compounds
    • C11D1/667—Neutral esters, e.g. sorbitan esters
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D1/00—Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
    • C11D1/66—Non-ionic compounds
    • C11D1/74—Carboxylates or sulfonates esters of polyoxyalkylene glycols
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/0005—Other compounding ingredients characterised by their effect
    • C11D3/0078—Compositions for cleaning contact lenses, spectacles or lenses
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/48—Medical, disinfecting agents, disinfecting, antibacterial, germicidal or antimicrobial compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Inorganic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Eyeglasses (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invención se refiere a una composición oftálmica caracterizada porque comprende del 0,005% en peso al 2,0% en peso de ceras naturales alcoxiladas seleccionadas del grupo que consiste en lanolina alcoxilada y jojoba alcoxilada, y del 0, 002% en peso al 0,2% en peso de ácido hialurónico o del 0, 05% en peso al 0, 3% en peso de hidroxipropil guar.
MX2014009949A 2012-02-24 2013-01-10 Composiciones oftalmicas con ceras alcoxiladas naturales. MX350201B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261602764P 2012-02-24 2012-02-24
PCT/US2013/020998 WO2013126155A1 (en) 2012-02-24 2013-01-10 Ophthalmic compositions with alkoxylated natural waxes

Publications (2)

Publication Number Publication Date
MX2014009949A MX2014009949A (es) 2014-11-10
MX350201B true MX350201B (es) 2017-08-30

Family

ID=47757683

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014009949A MX350201B (es) 2012-02-24 2013-01-10 Composiciones oftalmicas con ceras alcoxiladas naturales.

Country Status (11)

Country Link
US (1) US9375401B2 (es)
EP (1) EP2816996B1 (es)
JP (1) JP2015509495A (es)
KR (1) KR101726029B1 (es)
CN (1) CN104136005A (es)
AU (1) AU2013222801B2 (es)
CA (1) CA2864833C (es)
ES (1) ES2609013T3 (es)
MX (1) MX350201B (es)
PL (1) PL2816996T3 (es)
WO (1) WO2013126155A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020123362A1 (en) 2018-12-10 2020-06-18 EternaTear, Inc. Ophthalmic formulations providing durable ocular lubrication
KR102365008B1 (ko) * 2020-06-23 2022-02-23 주식회사태준제약 디쿠아포솔을 포함하는 점안 조성물
US11471475B1 (en) 2022-03-08 2022-10-18 Ralph P. Stone Ophthalmic suspension vehicles and related methods for pharmaceutical ingredient delivery
US11679078B1 (en) 2022-03-08 2023-06-20 EternaTear, Inc. Ophthalmic formulations and related methods

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3374144A (en) * 1965-10-07 1968-03-19 Miles Lab Ophthalmic composition
US4409205A (en) 1979-03-05 1983-10-11 Cooper Laboratories, Inc. Ophthalmic solution
US4758595A (en) 1984-12-11 1988-07-19 Bausch & Lomb Incorporated Disinfecting and preserving systems and methods of use
US5209927A (en) 1985-01-23 1993-05-11 Alcon Laboratories, Inc. Ophthalmic solution
DE69115990T2 (de) 1990-05-29 1996-05-30 Ocular Res Of Bonton Inc Zusammensetzung zur Behandlung von Dry Eye Erkrankungen
JPH0477434A (ja) 1990-07-17 1992-03-11 Kanji Takada 顆粒球コロニー刺激因子の眼粘膜適用製剤
JP2000109892A (ja) 1998-10-02 2000-04-18 Rohto Pharmaceut Co Ltd 多糖含有コンタクトレンズ用液剤
JP2002308775A (ja) 2001-04-06 2002-10-23 Rohto Pharmaceut Co Ltd 外用組成物
JP2003081840A (ja) * 2001-07-04 2003-03-19 Rohto Pharmaceut Co Ltd 清涼化方法、清涼化剤および外用組成物
US6695123B2 (en) 2001-12-21 2004-02-24 Richwood Industries, Inc. Conveyor belt cleaner blade
TWI322828B (en) 2002-12-23 2010-04-01 Alcon Inc Use of multifunctional surface active agents to clean contact lenses
US20040137079A1 (en) * 2003-01-08 2004-07-15 Cook James N. Contact lens and eye drop rewetter compositions and methods
JP2004238346A (ja) * 2003-02-07 2004-08-26 Shiono Chemical Co Ltd トラニラストの安定な水溶液製剤
US20050196370A1 (en) * 2003-03-18 2005-09-08 Zhi-Jian Yu Stable ophthalmic oil-in-water emulsions with sodium hyaluronate for alleviating dry eye
WO2006079830A1 (en) 2005-01-29 2006-08-03 Croda International Plc Alkoxylated lanolin derivatives and compositions therewith
CN101185650B (zh) * 2006-11-27 2010-07-28 中国医学科学院医药生物技术研究所 喷昔洛韦眼用温度敏感原位凝胶制剂及其制备方法
US8119112B2 (en) 2008-01-31 2012-02-21 Bausch & Lomb Incorporated Ophthalmic compositions with an amphoteric surfactant and hyaluronic acid
US8802653B2 (en) * 2010-10-01 2014-08-12 C.B. Fleet Company, Inc. Deodorant compositions

Also Published As

Publication number Publication date
MX2014009949A (es) 2014-11-10
EP2816996A1 (en) 2014-12-31
US20150297511A1 (en) 2015-10-22
WO2013126155A1 (en) 2013-08-29
AU2013222801B2 (en) 2015-09-17
US9375401B2 (en) 2016-06-28
JP2015509495A (ja) 2015-03-30
AU2013222801A1 (en) 2014-09-04
CA2864833C (en) 2017-01-03
ES2609013T3 (es) 2017-04-18
EP2816996B1 (en) 2016-10-05
CN104136005A (zh) 2014-11-05
KR20140124859A (ko) 2014-10-27
CA2864833A1 (en) 2013-08-29
PL2816996T3 (pl) 2017-04-28
KR101726029B1 (ko) 2017-04-11

Similar Documents

Publication Publication Date Title
MY169328A (en) Compositions for the treatment of dry eye
MY171920A (en) Prevention and treatment of ocular conditions
SG10201809290SA (en) Compositions and Methods to Treating Hemoglobinopathies
MA39767A (fr) Solution aqueuse ophtalmique et méthode de traitement du syndrome de l'oeil sec
WO2013061309A3 (en) New a-prp medical device & tissue engineering composition, manufacturing machines and process
MX2013004061A (es) Analogos de ciclosporina.
MX359327B (es) Composiciones y sus usos para tratar y prevenir la enfermedad de huntington.
MX2012004551A (es) Nuevas composiciones para prevenir y/o tratar trastornos de almacenamiento lisosomal.
EA201591743A1 (ru) СТИМУЛЯТОРЫ sGC
NZ727304A (en) Compositions and methods of use of phorbol esters for the treatment of stroke
SG10201808104RA (en) Cenicriviroc for the treatment of fibrosis
MY180581A (en) A crystalline form of cyclosporine a, methods of preparation, and methods for use thereof
PH12017500922A1 (en) Stabilized omega-3 ophthalmic compositions
MX2016008226A (es) Metodos para el cuidado oral prebiotico usando un sacarido.
MX2013004062A (es) Analogos de ciclosporina.
PH12017500615A1 (en) Ophthalmic composition comprising cyclosporine and trehalose
WO2012080497A3 (en) Use of lp-pla2 inhibitors in the treatment and prevention of eye diseases
WO2016094834A3 (en) A method for treating a complement mediated disorder caused by an infectious agent in a patient
PH12017500637A1 (en) Inhibitors of lysine gingipain
MX350201B (es) Composiciones oftalmicas con ceras alcoxiladas naturales.
MX2017004760A (es) Formulacion esterilizada por calor que comprende quitosan y proceso para preparacion de la misma.
TW201613628A (en) Combination of valerian root extract and lavender oil for use in the treatment of sleep disorders
MX2019012375A (es) Formulaciones del inhibidor del antigeno-1 asociado a la funcion de linfocitos (lfa-1).
MX2013015419A (es) Dha y epa en la reduccion de estres oxidante.
BR112013021035A2 (pt) composições e métodos de reposição de tecido macio aperfeiçoados

Legal Events

Date Code Title Description
FG Grant or registration